IDAAPM: Integrated database of ADMET and adverse effects of predictive modeling based on FDA approved drug data

Journal of Cheminformatics

Volumn 8, Issue 1, 2016, Pages

  Legehar, Ashenafi ^a   Xhaard, Henri ^a   Ghemtio, Leo ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

ADMET; Adverse effects; Data analysis; Database; Drug target database; FDA approved drugs; Predictive modeling; Targets

Indexed keywords

EID: 84975143356     PISSN: None     EISSN: 17582946     Source Type: Journal    
DOI: 10.1186/s13321-016-0141-7     Document Type: Article

References (34)

1. Bunnage ME (2011) Getting pharmaceutical R&D back on target. Nat Chem Biol 7(6):335-339
2. Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J (2014) Clinical development success rates for investigational drugs. Nat Biotechnol 32(1):40-51
3. Kola I, Landis J (2004) Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3(8):711-715
4. Dearden JC (2007) In silico prediction of ADMET properties: how far have we come? Expert Opin Drug Metab Toxicol 3(5):635-639
5. Gleeson MP, Hersey A, Hannongbua S (2011) In-silico ADME models: a general assessment of their utility in drug discovery applications. Curr Top Med Chem 11(4):358-381
6. Gleeson MP, Modi S, Bender A, Robinson RL, Kirchmair J, Promkatkaew M, Hannongbua S, Glen RC (2012) The challenges involved in modeling toxicity data in silico: a review. Curr Pharm Des 18(9):1266-1291
7. Moroy G, Martiny VY, Vayer P, Villoutreix BO, Miteva MA (2012) Toward in silico structure-based ADMET prediction in drug discovery. Drug Discov Today 17(1-2):44-55
8. Raunio H (2011) In silico toxicology - non-testing methods. Front Pharmacol 2:33
9. Gleeson MP (2008) Generation of a set of simple, interpretable ADMET rules of thumb. J Med Chem 51(4):817-834
10. Leeson PD, Springthorpe B (2007) The influence of drug-like concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov 6(11):881-890
11. Lipinski CA (2000) Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 44(1):235-249
12. Price DA, Blagg J, Jones L, Greene N, Wager T (2009) Physicochemical drug properties associated with in vivo toxicological outcomes: a review. Expert Opin Drug Metab Toxicol 5(8):921-931
13. Hartung T, Hoffmann S (2009) Food for thought... on in silico methods in toxicology. Altex 26(3):155-166
14. Hou T (2015) Editorial. In silico ADMET predictions in pharmaceutical research. Adv Drug Deliv Rev 86:1
15. Modi S, Li J, Malcomber S, Moore C, Scott A, White A, Carmichael P (2012) Integrated in silico approaches for the prediction of Ames test mutagenicity. J Comput Aided Mol Des 26(9):1017-1033
16. Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu Y, Maciejewski A, Arndt D, Wilson M, Neveu V et al (2014) DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res 42(Database issue):D1091-D1097
17. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B et al (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40(D1):D1100-D1107
18. Gilson MK, Liu T, Baitaluk M, Nicola G, Hwang L, Chong J (2016) BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res 44(D1):D1045-D1053
19. Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Han L, He J, He S, Shoemaker BA et al (2016) PubChem substance and compound databases. Nucleic Acids Res 44(D1):D1202-D1213
20. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28(1):235-242
21. Wang RX, Fang XL, Lu YP, Wang SM (2004) The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures. J Med Chem 47(12):2977-2980
22. Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SP, Buneman OP, Davenport AP, McGrath JC, Peters JA et al (2016) The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucleic Acids Res 44(D1):D1054-D1068
23. Yang H, Qin C, Li YH, Tao L, Zhou J, Yu CY, Xu F, Chen Z, Zhu F, Chen YZ (2016) Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information. Nucleic Acids Res 44(D1):D1069-D1074
24. Miller MA, Hazard GF, Hudson VW, Hilt C, Fang J, Mayer D, Callahan L (2003) ChemIDplus: a free, web-based portal to a variety of compound-based information. Abstr Pap Am Chem Soc 226:U305
25. U.S. Food and Drug Administration DrugsatFDA. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/
26. Ahmad SR, Goetsch RA, Marks NS (2005) Spontaneous reporting in the United States. In: Strom BL (ed) Pharmacoepidemiology, 4th edn. Wiley, Chichester, UK, pp 135-159
27. Harpaz R, Haerian K, Chase HS, Friedman C (2010) Statistical mining of potential drug interaction adverse effects in FDA's spontaneous reporting system. AMIA Annu Symp Proc 2010:281-285
28. Morrissey KM, Wen CC, Johns SJ, Zhang L, Huang SM, Giacomini KM (2012) The UCSF-FDA transportal: a public drug transporter database. Clin Pharmacol Ther 92(5):545-546
29. Sedykh A, Fourches D, Duan J, Hucke O, Garneau M, Zhu H, Bonneau P, Tropsha A (2013) Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res 30(4):996-1007
30. Moda TL, Torres LG, Carrara AE, Andricopulo AD (2008) PK/DB: database for pharmacokinetic properties and predictive in silico ADME models. Bioinformatics 24(19):2270-2271
31. Kuhn M, Campillos M, Letunic I, Jensen LJ, Bork P (2010) A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol 6. doi: 10.1038/msb.2009.98
32. Cheng FX, Li WH, Wang XC, Zhou YD, Wu ZR, Shen J, Tang Y (2013) Adverse drug events: database construction and in silico prediction. J Chem Inf Model 53(4):744-752
33. Berthold MR, Cebron N, Dill F, Di Fatta G, Gabriel TR, Georg F, Meinl T, Ohl P, Sieb C, Wiswedel B (2006) Knime: The konstanz information miner. In: 4th international industrial simulation conference 2006, pp 58-61
34. Giannangelo K (2006) Principles to guide maintenance of classifications. In: Reichert A, Mihalas G, Stoicu-Tivadar L et al (eds) Proceedings of the EFMI special topic conference. Integrating biomedical information: from E-cell to E-patient, Timisoara, Romania, 6-8 April 2006. AKA-Verlag, Berlin, pp 293-297